Search bioRxiv⌕ Search

Biology subjects

Daou, B.

Publications and source records attributed to Daou, B..

2 recordsLinked to original sources

Tunable neuronal microenvironments drive distinct functional phenotypes in human iPSCs-derived dopaminergic neurons

Neuronal heterogeneity is a defining feature of complex neural circuits, where local differences in firing patterns, activity levels, and temporal dynamics shape information processing and emergent network activity. In adult neurons, this heterogeneity arises from a variety of known and unknown factors including the extracellular environment. Although neurons have been cultured on three-dimensional substrates, the effect of the microenvironments on their firing activity remains poorly understood. Here, we have synthesized two chitosan hydrogel systems seeded with human iPSCs-derived dopaminergic neurons as tunable platforms to control neuronal microenvironments. Both systems were formulated with the ability to incorporate carbon nanotubes (CNT), thus promoting neural interfacing. Calcium imaging combined with computational single-cell analysis demonstrated that supramolecular organization, hydration state, and general physicochemical properties differentially bias neuronal firing dynamics and synchrony leading to the emergence of distinct activity phenotypes despite identical cellular origin. These activity profiles were clustered through K-means and assigned to specific phenotypes including bursting irregular neurons, regular network contributors, or less active/quiescent neurons. Furthermore, CNTs incorporation enhanced local hydrogel compaction, resulting in unique active neuronal phenotypes, highlighting the potential of CNTs to modulate local cellular microenvironments. These findings establish tunable biomaterials as microenvironment contenders for controlling neuronal network state while giving insights on the interplay of different cues in promoting neuronal heterogeneity and functional phenotype relevant to neurodevelopment, neurodegeneration, and disease modelling.

neuroscience↗

Comprehensive characterization of skeletal muscle remodeling in hSOD1G93A mice reveals limited functional impact of systemic FOXO1 inhibition

BackgroundAmyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive motor neuron (MN) loss, muscle atrophy and paralysis. Although traditionally considered a MN-specific disease, accumulating evidence supports a crucial contribution of skeletal muscle pathology to disease onset and progression. Except for specific mutations, to date there is no effective treatment for ALS. FOXO transcription factors regulate programs of atrophy, metabolism and stress response in skeletal muscle, and their inhibition has shown beneficial effects in cellular and Drosophila models of ALS. MethodsIn this study, we investigated whether pharmacological FOXO inhibition (iFOXO) could modify disease progression and muscle pathology in female hSOD1G93A mice. Mice received daily oral administration of iFOXO starting at presymptomatic (P50; n=5 per group) or symptomatic (P90; n=9 mice per group) stages until end-stage. Body weight was monitored longitudinally, and motor performance was evaluated using grip strength and hanging-wire tests. Tibialis anterior and soleus muscles, representing fast- and slow-twitch muscles respectively, were analyzed by histology and immunofluorescence to assess fiber atrophy, fibrosis, lipid accumulation, satellite cell pool and fiber type composition. Quadriceps muscles (n=3 per group) were used for RNA-seq analysis. ResultsWhile histological analyses revealed severe fiber atrophy and increased fibrosis in hSOD1G93A mice, satellite cell numbers were preserved or mildly increased in a muscle and treatment onset dependent manner. iFOXO treatment did not improve motor performance, survival or attenuate muscle atrophy. Transcriptomic profiling indicated that genotype was the predominant driver of gene expression changes, while iFOXO produced only subtle, treatment onset dependent effects on pathways related to oxidative stress responses, mitochondrial function and adaptive metabolism. ConclusionOverall, FOXO inhibition alone showed limited therapeutic benefit in the hSOD1G93A ALS mouse model. These findings highlight the dominant influence of ALS driven molecular alterations over pharmacological modulation and emphasize the need for combinatorial therapeutic strategies targeting multiple disease mechanisms, including those preserving nerve health.

neuroscience↗